Additional file 2: Figure S1. of Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma

Response heterogeneity. All patient lesions as percentage change in diameter on CT scan relative to size at baseline until progressive disease. (PDF 52 kb)